Laparoscopic bipolar coagulation of uterine vessels to treat symptomatic myomas in women with elevated CA 125

Yuan Kuei Yen, Wei Min Liu, Chiou Chung Yuan, Heung Tat Ng

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Study Objective. To assess laparoscopic bipolar coagulation of uterine vessels (LBCUV) for symptomatic myomas in women with elevated CA 125 (>35 U/ml). Design. Prospective, longitudinal study (Canadian Task Force classification II-1). Setting. Private practice, university-affiliated hospital. Patients. Forty-six women (age 30-50 yrs) with symptomatic myomas and elevated CA 125 level. Intervention. Laparoscopic bipolar coagulation of uterine vessels performed over 10 months. Measurements and Main Results. All patients underwent successful LBCUV and coagulation of anastomotic site of uterine arteries with ovarian arteries without intraoperative complication. One, 3, and 6 months after treatment, respectively, 52.2%, 65.2%, and 71.7% of women reported improvement in menorrhagia, 19.6%, 45.7%, and 56.5% noted improvement in dysmenorrhea, and 6.5%, 16.1%, and 38.7% had improvement in bulk-related symptoms. Average reduction in uterine volume was 9.1%, 16.9%, and 38.3% and average reduction in dominant myoma was 12.1%, 23.9%, and 59.1% at those times; the average reduction of CA 125 in all patients was 39.8, 75.4, and 126.1 U/ml. Conclusion. Symptoms were improved and uterine volume and dominant myoma were reduced by LBCUV. The CA 125 level fell during follow-up in 40 patients (87.0%). Improvement in symptoms, especially menorrhagia, and shrinkage of uterine volume and dominant myoma seemed to be more pronounced in women with decreased than in those without decreased CA 125 after treatment (p = 0.045). The CA 125 level may be a valuable indicator for monitoring the efficacy of LBCUV.

Original languageEnglish
Pages (from-to)241-246
Number of pages6
JournalJournal of the American Association of Gynecologic Laparoscopists
Volume8
Issue number2
DOIs
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Myoma
Menorrhagia
Uterine Artery
Dysmenorrhea
Private Practice
Intraoperative Complications
Advisory Committees
Longitudinal Studies
Arteries
Prospective Studies
Therapeutics

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Laparoscopic bipolar coagulation of uterine vessels to treat symptomatic myomas in women with elevated CA 125. / Yen, Yuan Kuei; Liu, Wei Min; Yuan, Chiou Chung; Ng, Heung Tat.

In: Journal of the American Association of Gynecologic Laparoscopists, Vol. 8, No. 2, 2001, p. 241-246.

Research output: Contribution to journalArticle

@article{7512d527eeac44eda5d54329b109cc70,
title = "Laparoscopic bipolar coagulation of uterine vessels to treat symptomatic myomas in women with elevated CA 125",
abstract = "Study Objective. To assess laparoscopic bipolar coagulation of uterine vessels (LBCUV) for symptomatic myomas in women with elevated CA 125 (>35 U/ml). Design. Prospective, longitudinal study (Canadian Task Force classification II-1). Setting. Private practice, university-affiliated hospital. Patients. Forty-six women (age 30-50 yrs) with symptomatic myomas and elevated CA 125 level. Intervention. Laparoscopic bipolar coagulation of uterine vessels performed over 10 months. Measurements and Main Results. All patients underwent successful LBCUV and coagulation of anastomotic site of uterine arteries with ovarian arteries without intraoperative complication. One, 3, and 6 months after treatment, respectively, 52.2{\%}, 65.2{\%}, and 71.7{\%} of women reported improvement in menorrhagia, 19.6{\%}, 45.7{\%}, and 56.5{\%} noted improvement in dysmenorrhea, and 6.5{\%}, 16.1{\%}, and 38.7{\%} had improvement in bulk-related symptoms. Average reduction in uterine volume was 9.1{\%}, 16.9{\%}, and 38.3{\%} and average reduction in dominant myoma was 12.1{\%}, 23.9{\%}, and 59.1{\%} at those times; the average reduction of CA 125 in all patients was 39.8, 75.4, and 126.1 U/ml. Conclusion. Symptoms were improved and uterine volume and dominant myoma were reduced by LBCUV. The CA 125 level fell during follow-up in 40 patients (87.0{\%}). Improvement in symptoms, especially menorrhagia, and shrinkage of uterine volume and dominant myoma seemed to be more pronounced in women with decreased than in those without decreased CA 125 after treatment (p = 0.045). The CA 125 level may be a valuable indicator for monitoring the efficacy of LBCUV.",
author = "Yen, {Yuan Kuei} and Liu, {Wei Min} and Yuan, {Chiou Chung} and Ng, {Heung Tat}",
year = "2001",
doi = "10.1016/S1074-3804(05)60584-1",
language = "English",
volume = "8",
pages = "241--246",
journal = "Journal of Minimally Invasive Gynecology",
issn = "1553-4650",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Laparoscopic bipolar coagulation of uterine vessels to treat symptomatic myomas in women with elevated CA 125

AU - Yen, Yuan Kuei

AU - Liu, Wei Min

AU - Yuan, Chiou Chung

AU - Ng, Heung Tat

PY - 2001

Y1 - 2001

N2 - Study Objective. To assess laparoscopic bipolar coagulation of uterine vessels (LBCUV) for symptomatic myomas in women with elevated CA 125 (>35 U/ml). Design. Prospective, longitudinal study (Canadian Task Force classification II-1). Setting. Private practice, university-affiliated hospital. Patients. Forty-six women (age 30-50 yrs) with symptomatic myomas and elevated CA 125 level. Intervention. Laparoscopic bipolar coagulation of uterine vessels performed over 10 months. Measurements and Main Results. All patients underwent successful LBCUV and coagulation of anastomotic site of uterine arteries with ovarian arteries without intraoperative complication. One, 3, and 6 months after treatment, respectively, 52.2%, 65.2%, and 71.7% of women reported improvement in menorrhagia, 19.6%, 45.7%, and 56.5% noted improvement in dysmenorrhea, and 6.5%, 16.1%, and 38.7% had improvement in bulk-related symptoms. Average reduction in uterine volume was 9.1%, 16.9%, and 38.3% and average reduction in dominant myoma was 12.1%, 23.9%, and 59.1% at those times; the average reduction of CA 125 in all patients was 39.8, 75.4, and 126.1 U/ml. Conclusion. Symptoms were improved and uterine volume and dominant myoma were reduced by LBCUV. The CA 125 level fell during follow-up in 40 patients (87.0%). Improvement in symptoms, especially menorrhagia, and shrinkage of uterine volume and dominant myoma seemed to be more pronounced in women with decreased than in those without decreased CA 125 after treatment (p = 0.045). The CA 125 level may be a valuable indicator for monitoring the efficacy of LBCUV.

AB - Study Objective. To assess laparoscopic bipolar coagulation of uterine vessels (LBCUV) for symptomatic myomas in women with elevated CA 125 (>35 U/ml). Design. Prospective, longitudinal study (Canadian Task Force classification II-1). Setting. Private practice, university-affiliated hospital. Patients. Forty-six women (age 30-50 yrs) with symptomatic myomas and elevated CA 125 level. Intervention. Laparoscopic bipolar coagulation of uterine vessels performed over 10 months. Measurements and Main Results. All patients underwent successful LBCUV and coagulation of anastomotic site of uterine arteries with ovarian arteries without intraoperative complication. One, 3, and 6 months after treatment, respectively, 52.2%, 65.2%, and 71.7% of women reported improvement in menorrhagia, 19.6%, 45.7%, and 56.5% noted improvement in dysmenorrhea, and 6.5%, 16.1%, and 38.7% had improvement in bulk-related symptoms. Average reduction in uterine volume was 9.1%, 16.9%, and 38.3% and average reduction in dominant myoma was 12.1%, 23.9%, and 59.1% at those times; the average reduction of CA 125 in all patients was 39.8, 75.4, and 126.1 U/ml. Conclusion. Symptoms were improved and uterine volume and dominant myoma were reduced by LBCUV. The CA 125 level fell during follow-up in 40 patients (87.0%). Improvement in symptoms, especially menorrhagia, and shrinkage of uterine volume and dominant myoma seemed to be more pronounced in women with decreased than in those without decreased CA 125 after treatment (p = 0.045). The CA 125 level may be a valuable indicator for monitoring the efficacy of LBCUV.

UR - http://www.scopus.com/inward/record.url?scp=0034752015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034752015&partnerID=8YFLogxK

U2 - 10.1016/S1074-3804(05)60584-1

DO - 10.1016/S1074-3804(05)60584-1

M3 - Article

C2 - 11342731

AN - SCOPUS:0034752015

VL - 8

SP - 241

EP - 246

JO - Journal of Minimally Invasive Gynecology

JF - Journal of Minimally Invasive Gynecology

SN - 1553-4650

IS - 2

ER -